DK124824B - Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.

Info

Publication number
DK124824B
DK124824B DK128567AA DK128567A DK124824B DK 124824 B DK124824 B DK 124824B DK 128567A A DK128567A A DK 128567AA DK 128567 A DK128567 A DK 128567A DK 124824 B DK124824 B DK 124824B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
piperazine derivatives
analogous process
Prior art date
Application number
DK128567AA
Other languages
Danish (da)
English (en)
Inventor
J Delobelle
Der Burg W Van
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of DK124824B publication Critical patent/DK124824B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK128567AA 1966-03-12 1967-03-10 Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. DK124824B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (esLanguage) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
DK124824B true DK124824B (da) 1972-11-27

Family

ID=19795968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK128567AA DK124824B (da) 1966-03-12 1967-03-10 Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.

Country Status (13)

Country Link
US (1) US3534041A (esLanguage)
BE (1) BE695304A (esLanguage)
BR (1) BR6787719D0 (esLanguage)
CH (1) CH501647A (esLanguage)
DE (2) DE1695556C3 (esLanguage)
DK (1) DK124824B (esLanguage)
ES (1) ES337526A1 (esLanguage)
FI (1) FI51694C (esLanguage)
FR (1) FR6764M (esLanguage)
GB (1) GB1173783A (esLanguage)
GR (1) GR37262B (esLanguage)
NL (2) NL6603256A (esLanguage)
SE (1) SE331999B (esLanguage)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
GB2091247B (en) * 1980-12-31 1984-07-18 Beecham Group Ltd Pentacyclic compounds processes for their preparation and their use
DE3368634D1 (en) * 1982-03-05 1987-02-05 Beecham Group Plc Pentacyclic compounds
EP0090552A3 (en) * 1982-03-27 1984-04-25 Beecham Group Plc Pentacyclic compounds
EP0126343A1 (en) * 1983-05-18 1984-11-28 Beecham Group Plc Treatment of diarrhoea
EP0134984B1 (en) * 1983-07-16 1988-07-13 Beecham Group Plc Benzazepine and benzoxazepine derivatives
WO1988007997A1 (en) * 1987-04-10 1988-10-20 Monash University 1,2,3,4,10,14b-HEXAHYDRODIBENZO[c,f]PYRAZINO-[1,2-a]AZEPINO DERIVATIVES AND 10-AZA, 10-OXA AND 10-THIA ANALOGUES
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
EP0475482B1 (en) 1990-09-13 1994-10-05 Akzo Nobel N.V. Stabilized solid chemical compositions
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1017695A4 (en) * 1997-09-26 2002-01-16 Univ Monash RESOLUTION OF OPTICALLY ACTIVE COMPOUNDS
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
DE602004024317D1 (de) 2003-09-12 2010-01-07 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
CN101115726A (zh) 2004-12-03 2008-01-30 先灵公司 作为cb1拮抗剂的取代哌嗪
AU2006269231A1 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
BRPI0618643A2 (pt) 2005-11-09 2011-09-06 Combinatorx Inc composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
PE20071320A1 (es) 2006-01-18 2007-12-29 Schering Corp Moduladores de receptores cannabinoides
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
CN101796033A (zh) 2007-06-28 2010-08-04 英特维特国际股份有限公司 作为cb1拮抗剂的取代的哌嗪
EP2288345B1 (en) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Psycho-pharmaceuticals
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
GB1173783A (en) 1969-12-10
FR6764M (esLanguage) 1969-03-10
SE331999B (esLanguage) 1971-01-25
BR6787719D0 (pt) 1973-12-26
NL6603256A (esLanguage) 1967-09-13
US3534041A (en) 1970-10-13
DE1695556B2 (de) 1980-10-30
FI51694C (fi) 1977-03-10
FI51694B (esLanguage) 1976-11-30
DE1695556A1 (de) 1972-01-20
BE695304A (esLanguage) 1967-09-11
ES337526A1 (es) 1968-03-01
GR37262B (el) 1969-05-10
CH501647A (de) 1971-01-15
DE1795836B1 (de) 1977-11-24
DE1795836C2 (de) 1978-07-20
NL129434C (esLanguage)
DE1695556C3 (de) 1981-06-25

Similar Documents

Publication Publication Date Title
DK124824B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK125417B (da) Analogifremgangsmåde til fremstilling af amino-dihalogenphenylethylaminer eller syreadditionssalte deraf.
DK104409C (da) Fremgangsmåde til fremstilling af quinazolonderivater eller syreadditionssalte deraf.
DK120750B (da) Analogifremgangsmåde til fremstilling af azaspiroalkandion-forbindelser eller syreadditionssalte deraf.
DK123655B (da) Analogifremgangsmåde til fremstilling af pyridoindolderivater eller syreadditionssalte deraf.
DK121302B (da) Fremgangsmåde til fremstilling af imidazolderivater eller syreadditionssalte deraf.
DK120389B (da) Fremgangsmåde til fremstilling af 2-cycloalkylaminooxazoliner eller syreadditionssalte deraf.
DK132411B (da) Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf.
DK116362B (da) Fremgangsmåde til fremstilling af basisk substituerede benzothiazepinderivater eller syreadditionssalte deraf.
DK119059B (da) Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf.
DK118607B (da) Analogifremgangsmåde til fremstilling af 2-phenylhydrazino-imidazolin-2-forbindelser eller syreadditionssalte deraf.
DK121606B (da) Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte deraf.
DK111489B (da) Fremgangsmåde til fremstilling af benzodiazepinderivater eller 4-oxider eller syreadditionssalte deraf.
DK129924B (da) Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf.
DK115849B (da) Fremgangsmåde til fremstilling af substituerede 2-anilinomethyl-imidazoliner eller syreaddtitionssalte heraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK120998B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK120133B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK103831C (da) Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf.
DK116662B (da) Fremgangsmåde til fremstilling af pyrazinamider eller syreadditionssalte deraf.
DK113077B (da) Fremgangsmåde til fremstilling af basiske ethano-anthracenderivater eller syreadditionssalte deraf.
DK111072B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK121604B (da) Fremgangsmåde til fremstilling af substituerede iminocycloheptatrienderivater eller syreadditionssalte heraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK125921B (da) Analogifremgangsmåden til fremstilling af thiazepinderivater eller syreadditionssalte deraf.

Legal Events

Date Code Title Description
PUP Patent expired